Abstract

The recognition of serum amyloid A protein (SAA: the putative precursor of reactive amyloid fibril protein AA) as an acute phase reactant made it possible for us predictably to induce its synthesis under experimental conditions (1, 2). This together with the immunoradioassay and other biochemical methodologies that serve as tools to monitor the fluctuation of the SAA levels in a precise manner has contributed greatly to the definition of the cellular and molecular synthesis of SAA, one of the key factors in amyloidogenesis (1, 3–5). Recently, the molecular biological technology has further advanced our understanding of the hepatic and extrahepatic synthesis of SAA (6–12). Because these technologies primarily assay homogenates of tissues which consist of heterogenous cell populations, individual cell types that participate in SAA synthesis have not yet been clearly defined, with possible exception of hepatocytes that have been considered to be a major source of SAA.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.